ZA763652B - Pharmacologically active compounds - Google Patents

Pharmacologically active compounds

Info

Publication number
ZA763652B
ZA763652B ZA763652A ZA763652A ZA763652B ZA 763652 B ZA763652 B ZA 763652B ZA 763652 A ZA763652 A ZA 763652A ZA 763652 A ZA763652 A ZA 763652A ZA 763652 B ZA763652 B ZA 763652B
Authority
ZA
South Africa
Prior art keywords
active compounds
pharmacologically active
pharmacologically
compounds
active
Prior art date
Application number
ZA763652A
Other languages
English (en)
Inventor
C Ganellin
R Young
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA763652B publication Critical patent/ZA763652B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA763652A 1975-07-31 1976-06-18 Pharmacologically active compounds ZA763652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31971/75A GB1563090A (en) 1975-07-31 1975-07-31 Cyclobutene-diones

Publications (1)

Publication Number Publication Date
ZA763652B true ZA763652B (en) 1977-05-25

Family

ID=10331111

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA763652A ZA763652B (en) 1975-07-31 1976-06-18 Pharmacologically active compounds

Country Status (9)

Country Link
US (1) US4062863A (xx)
JP (1) JPS5219664A (xx)
AU (1) AU503067B2 (xx)
BE (1) BE843839A (xx)
DE (1) DE2634429A1 (xx)
FR (1) FR2319342A1 (xx)
GB (1) GB1563090A (xx)
IE (1) IE44124B1 (xx)
ZA (1) ZA763652B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
EP0014057B1 (en) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidine derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4510309A (en) * 1981-03-03 1985-04-09 Bristol-Myers Company Histamine H2 -antagonists
US4539316A (en) * 1981-05-18 1985-09-03 Bristol-Myers Company Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
US4522943A (en) * 1981-05-18 1985-06-11 Bristol-Myers Company Chemical compounds
US4788184A (en) * 1981-05-18 1988-11-29 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
US4395553A (en) * 1981-05-18 1983-07-26 Bristol-Myers Company Chemical compounds
US4526973A (en) * 1981-05-18 1985-07-02 Bristol-Myers Company Chemical compounds
US4546188A (en) * 1981-05-18 1985-10-08 Bristol-Myers Company Substituted 1,2-diaminocyclobutene-3,4-diones
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4525477A (en) * 1981-12-02 1985-06-25 Smith Kline & French Laboratories Limited 2-Thiazolyl, isothiazolyl, oxazolyl and isoxazolyl alkylamino-3-nitro-heterocyclic compounds
JPS58190097A (ja) * 1982-04-30 1983-11-05 日本メクトロン株式会社 回路基板の製造法
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
AU1956283A (en) * 1982-10-02 1984-04-05 Smith Kline & French Laboratories Limited 1-(3-(4-(substited aminomethyl)pyrid-2-yl-oxy)-prop-1-yl- amino) - 2-aminocyclobut-i-ene-3,4-diones
EP0112704B1 (en) * 1982-12-23 1987-10-07 Smith Kline & French Laboratories Limited Pyridine derivatives
DE3408327A1 (de) * 1984-03-07 1985-09-12 Ludwig Heumann & Co GmbH, 8500 Nürnberg Diaminderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS60255756A (ja) * 1984-06-01 1985-12-17 Ikeda Mohandou:Kk アミノアルキルフエノキシ誘導体
US4927968A (en) * 1987-05-14 1990-05-22 Bristol-Myers Company Chemical intermediates and process
US5168103A (en) * 1991-01-22 1992-12-01 American Home Products Corporation [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl) amino]alkyl]-acid derivatives
CN111349014A (zh) * 2020-03-30 2020-06-30 绵阳达高特新材料有限公司 一种方酸甲胺甲酯的制备方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Also Published As

Publication number Publication date
GB1563090A (en) 1980-03-19
DE2634429A1 (de) 1977-02-10
FR2319342B1 (xx) 1978-11-17
US4062863A (en) 1977-12-13
JPS5219664A (en) 1977-02-15
AU1645176A (en) 1978-02-02
BE843839A (fr) 1977-01-06
IE44124L (en) 1977-01-31
FR2319342A1 (fr) 1977-02-25
IE44124B1 (en) 1981-08-26
AU503067B2 (en) 1979-08-23

Similar Documents

Publication Publication Date Title
ZA763652B (en) Pharmacologically active compounds
ZA767198B (en) Pharmacologically active compounds
ZA765498B (en) Pharmacologically active compounds
PT67046A (en) Pharmacologically active compounds
ZM9876A1 (en) Pharmacologically active compounds
ZA7682B (en) Pharmacologically active compounds
ZA765331B (en) Novel pharmaceutically active compounds
ZM9676A1 (en) Pharmacologically active compounds
MW977A1 (en) Pharmacologically active compounds
ZA761324B (en) Pharmaceutically active compounds
ZA763837B (en) Pharmacologically active compounds
ZA762536B (en) Pharmacologically active compounds
PT65839A (en) Pharmacologically active compounds
ZA774220B (en) Pharmacologically active compounds
ZA774221B (en) Pharmacologically active compounds
ZA774552B (en) Pharmacologically active compounds
ZA774500B (en) Pharmacologically active compounds
ZA77508B (en) Pharmacologically active compounds
PT65759A (en) Pharmacologically active compounds
AU1059176A (en) Pharmacologically active compositions
ZM7377A1 (en) Pharmacologically active compounds
MW2676A1 (en) Pharmacologically active compounds
MW2876A1 (en) Pharmacologically active compounds
MW2776A1 (en) Pharmacologically active compounds